Search Orphan Drug Designations and Approvals
-
Generic Name: | Lisofylline |
---|---|
Date Designated: | 06/10/1999 |
Orphan Designation: | Treatment of patients undergoing induction therapy for acute myeloid leukemia. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Cell Therapeutics, Inc. 501 Elliott Avenue West Suite 400 Seattle, Washington 98119 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-